The mRNA levels of the CD1D gene in RA-differentiated cells from patient glioblastoma stem-like cells were higher than the levels in patient glioblastoma stem-like cells, suggesting that CD1d expression was elevated (Fig. 4b). The gene discussed is CD1D; the disease is glioblastoma.